Banque de Luxembourg Investments (BLI)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Banque de Luxembourg Investments (BLI)'s GILD Position: Q2 2026 in Review
Banque de Luxembourg Investments (BLI) increased its Gilead Sciences (GILD) stake by 1,687% in Q2 2026, buying an estimated $5.63M and bringing the position to 45,231 shares worth $5.73M. The position accounts for 0.2% of the portfolio, ranked #119.
Banque de Luxembourg Investments (BLI) first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. 1,455 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Banque de Luxembourg Investments (BLI) held 45,231 shares of Gilead Sciences worth $5.73M as of Q2 2026.
- Banque de Luxembourg Investments (BLI) bought 42,700 Gilead Sciences shares in Q2 2026, an estimated $5.63M.
- Gilead Sciences made up 0.2% of Banque de Luxembourg Investments (BLI)'s portfolio in Q2 2026, its #119 holding.
- Banque de Luxembourg Investments (BLI) first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
- 1,455 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Banque de Luxembourg Investments (BLI)'s 13F filing for Q2 2026, filed 10 Aug 2026.